[1] 谭盛葵,王维伟,刘顺,等.h MSH2基因多态性和环境因素的交互作用与肝细胞癌的关系.中华肝脏病杂志,2014,22:676-679. [2] 陈薇,陈靖,郑琦,等.乙型肝炎病毒相关性肝细胞癌预测模型的验证.中华肝脏病杂志,2015,23:507-511. [3] 王镇,王德阳,邢曜耀,等.肝细胞癌螺旋CT多期扫描边缘强化的鉴别诊断价值.中国老年学杂志,2013,33:1188-1189. [4] 江婷,许杰华,王劲,等.磁共振弥散加权成像信号强度评价肝细胞癌组织分化程度的价值.中华肝胆外科杂志,2015,21:76-80. [5] 陈文彬,潘祥林.诊断学.第7版.北京:人民卫生出版社.2008:22-24. [6] Xiao L,Zhang RL,Zhang H et al.Comparison of the clinical characteristics and survival between Uyghur patients with hepatitis virus-related and non-B,non-C hepatocellular carcinoma in Xinjiang,China.Chin J Cancer Res,2015,27:279-287. [7] Levi Sandri GB,Vennarecci G,Santoro R,et al.Laparoscopic left liver Iobectomy for hepatocellular carcinoma in a cirrhotic patient:a video report.Chin J Cancer Res,2014,26:735-736. [8] 胡博,孙超,孙鼎,等.姜黄素纳米粒(NanoCurc TM)联合索拉非尼对肝细胞癌(HCC)的协同抑制作用.复旦学报(医学版),2014,41:143-148. [9] Abul Seoud RA,Mabrouk MS.TMT-HCC:a tool for text mining the biomedical literature for hepatocellular carcinoma(HCC)biomarkers identification.Comput Methods Programs Biomed,2013,112:640-648. [10] 韦绍全. 螺旋CT动态多期扫描在肝细胞癌诊断中的应用.中国民族民间医药,2013,22:75-75. [11] 刘学聪,刘宝玲,宋丹丹,等.64层螺旋CT多期动态增强扫描肝细胞肝癌诊断的临床分析.医学影像学杂志,2015,25:1481-1484. [12] 崔雄伟,郑加生,钱智玲,等.肝细胞癌CT动态增强密度与肿瘤分化程度、CD34、CK19、GPC3、P53、Ki67表达的多因素相关性分析.北京医学,2014,36:724-727. [13] 黄智标. 螺旋CT动态多期扫描在肝细胞癌诊断中的应用.中国民族民间医药,2013,22:19. [14] 李建芳,丁世雄,应丽萍,等.小干扰RNA下调Notch2对肝细胞癌HepG2细胞增殖的影响.中华肝脏病杂志,2014,22:354-357. [15] 刘延华. 螺旋CT动态多期扫描在肝细胞癌诊断中的应用价值探讨.河北医学,2015,21:1134-1136. |